Summary
Glenmark is one of the steady players in Indian Pharma industry.
Its has done many things right in its business, and currently dominates many verticals where they are present
The forth coming IPO is a good opportunity to consider the stock.
Analysis
Glenamrk has been present for considerable time now.
In terms of pharma business, they know the game well.
With good local & international presence, promising set of products, the company seems set for good returns.
Glenmark IPO / Pre IPO placement would make a sensible buy.
Going by the current Indian market, Glenmark would be one of the few pharma offerings.
In the medium to long term Glenmark makes a good buy.
The pipe line is strong despite the recent set backs received from clinical trial results.
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
